Literature DB >> 18612771

Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings.

Luca Padua1, Tiziana Cavallaro, Davide Pareyson, Aldo Quattrone, Giuseppe Vita, Angelo Schenone.   

Abstract

Pain is not considered a relevant symptom in Charcot-Marie-Tooth (CMT) patients and no studies have comprehensively assessed it. We performed a multidimensional assessment in 211 consecutive CMT patients to evaluate the clinical features, quality of life (QoL) and disability. For QoL we used the SF-36, which comprises one domain called "Bodily Pain" (BP), which is a generic measure of intensity of pain. Results showed that pain is a relevant symptom related to gender, CMT subtypes, clinical picture, disability, and mildly to neurophysiological impairment. In our study the importance of pain was an occasional finding. Because of the study design we are not able to ascertain if pain is primarily due to the neuropathy or if it is due to the muscoloskeletal deformities arising as a consequence of the neuropathy. Our study underlined that pain should be considered as a relevant symptom in CMT patients and further studies should be performed.

Entities:  

Mesh:

Year:  2008        PMID: 18612771     DOI: 10.1007/s10072-008-0935-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study.

Authors:  L Padua; I Aprile; T Cavallaro; I Commodari; G La Torre; D Pareyson; A Quattrone; N Rizzuto; G Vita; P Tonali; A Schenone
Journal:  Neurol Sci       Date:  2006-12       Impact factor: 3.307

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Quality of life in patients with Charcot-Marie-Tooth disease.

Authors:  P Vinci; M Serrao; A Millul; A Deidda; F De Santis; S Capici; D Martini; F Pierelli; V Santilli
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

4.  Improving the sensitivity of the Barthel Index for stroke rehabilitation.

Authors:  S Shah; F Vanclay; B Cooper
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

Review 5.  The tools of disability outcomes research functional status measures.

Authors:  M E Cohen; R J Marino
Journal:  Arch Phys Med Rehabil       Date:  2000-12       Impact factor: 3.966

6.  Motor and functional recovery after stroke: accuracy of physical therapists' predictions.

Authors:  N Korner-Bitensky; N Mayo; R Cabot; R Becker; H Coopersmith
Journal:  Arch Phys Med Rehabil       Date:  1989-02       Impact factor: 3.966

Review 7.  Charcot-marie-tooth disease and related neuropathies: molecular basis for distinction and diagnosis.

Authors:  D Pareyson
Journal:  Muscle Nerve       Date:  1999-11       Impact factor: 3.217

  7 in total
  9 in total

1.  Exploring neuropathic symptoms in a large cohort of Italian patients with different peripheral nervous system diseases.

Authors:  Marta Lucchetta; Costanza Pazzaglia; Luca Padua; Chiara Briani
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

2.  Effect of pain in pediatric inherited neuropathies.

Authors:  Sindhu Ramchandren; Mamta Jaiswal; Eva Feldman; Michael Shy
Journal:  Neurology       Date:  2014-01-29       Impact factor: 9.910

3.  Functional MRI and laser-evoked potentials evaluation in Charcot-Marie-Tooth syndrome.

Authors:  Simona De Salvo; Lilla Bonanno; Roberto Giorgianni; Nunzio Muscarà; Francesco Freni; Fabrizia Caminiti; Demetrio Milardi; Placido Bramanti; Silvia Marino
Journal:  Neurol Sci       Date:  2018-04-11       Impact factor: 3.307

Review 4.  Chronic pain in neuromuscular disease: pain site and intensity differentially impacts function.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-17       Impact factor: 1.784

5.  Inherited neuropathies.

Authors:  Angelo Schenone; Lucilla Nobbio; Margherita Monti Bragadin; Giulia Ursino; Marina Grandis
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

6.  Oral health, temporomandibular disorder, and masticatory performance in patients with Charcot-Marie-Tooth type 2.

Authors:  Rejane L S Rezende; Leonardo R Bonjardim; Eduardo L A Neves; Lidiane C L Santos; Paula S Nunes; Catarina A Garcez; Cynthia C Souza; Adriano A S Araújo
Journal:  ScientificWorldJournal       Date:  2013-12-10

7.  Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.

Authors:  Katy Eichinger; Janet E Sowden; Joshua Burns; Michael P McDermott; Jeffrey Krischer; John Thornton; Davide Pareyson; Steven S Scherer; Michael E Shy; Mary M Reilly; David N Herrmann
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

8.  Catheter-based distal sciatic nerve block in patients with Charcot-Marie-Tooth disease.

Authors:  Hubert J Schmitt; Sandra Huberth; Horst Huber; Tino Münster
Journal:  BMC Anesthesiol       Date:  2014-02-14       Impact factor: 2.217

Review 9.  Neuropathic pain in hereditary peripheral neuropathy.

Authors:  Na Young Jeong; Youn Ho Shin; Junyang Jung
Journal:  J Exerc Rehabil       Date:  2013-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.